277 related articles for article (PubMed ID: 37330043)
1. IL-33's role in the gut immune system: A comprehensive review of its crosstalk and regulation.
Kaur H; Kaur G; Ali SA
Life Sci; 2023 Aug; 327():121868. PubMed ID: 37330043
[TBL] [Abstract][Full Text] [Related]
2. Development, validation and implementation of an in vitro model for the study of metabolic and immune function in normal and inflamed human colonic epithelium.
Pedersen G
Dan Med J; 2015 Jan; 62(1):B4973. PubMed ID: 25557335
[TBL] [Abstract][Full Text] [Related]
3. Interleukin-33 (IL-33): A critical review of its biology and the mechanisms involved in its release as a potent extracellular cytokine.
Cayrol C; Girard JP
Cytokine; 2022 Aug; 156():155891. PubMed ID: 35640416
[TBL] [Abstract][Full Text] [Related]
4. Pro- and anti-inflammatory roles of interleukin (IL)-33, IL-36, and IL-38 in inflammatory bowel disease.
Andoh A; Nishida A
J Gastroenterol; 2023 Feb; 58(2):69-78. PubMed ID: 36376594
[TBL] [Abstract][Full Text] [Related]
5. IL-33 Alarmin and Its Active Proinflammatory Fragments Are Released in Small Intestine in Celiac Disease.
Perez F; Ruera CN; Miculan E; Carasi P; Dubois-Camacho K; Garbi L; Guzman L; Hermoso MA; Chirdo FG
Front Immunol; 2020; 11():581445. PubMed ID: 33133101
[TBL] [Abstract][Full Text] [Related]
6. Novel cytokine signaling pathways in inflammatory bowel disease: insight into the dichotomous functions of IL-33 during chronic intestinal inflammation.
Pastorelli L; De Salvo C; Cominelli MA; Vecchi M; Pizarro TT
Therap Adv Gastroenterol; 2011 Sep; 4(5):311-23. PubMed ID: 21922030
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-33 (IL-33): A nuclear cytokine from the IL-1 family.
Cayrol C; Girard JP
Immunol Rev; 2018 Jan; 281(1):154-168. PubMed ID: 29247993
[TBL] [Abstract][Full Text] [Related]
8. ILC2 require cell-intrinsic ST2 signals to promote type 2 immune responses.
Topczewska PM; Rompe ZA; Jakob MO; Stamm A; Leclère PS; Preußer A; Duerr CU; Thole LML; Kotsch K; Artis D; Klose CSN
Front Immunol; 2023; 14():1130933. PubMed ID: 37063913
[TBL] [Abstract][Full Text] [Related]
9. IL-33 controls IL-22-dependent antibacterial defense by modulating the microbiota.
Röwekamp I; Maschirow L; Rabes A; Fiocca Vernengo F; Hamann L; Heinz GA; Mashreghi MF; Caesar S; Milek M; Fagundes Fonseca AC; Wienhold SM; Nouailles G; Yao L; Mousavi S; Bruder D; Boehme JD; Puzianowska-Kuznicka M; Beule D; Witzenrath M; ; Löhning M; Klose CSN; Heimesaat MM; Diefenbach A; Opitz B
Proc Natl Acad Sci U S A; 2024 May; 121(22):e2310864121. PubMed ID: 38781213
[TBL] [Abstract][Full Text] [Related]
10. Role of interleukin-33 in innate-type immune cells in allergy.
Nakae S; Morita H; Ohno T; Arae K; Matsumoto K; Saito H
Allergol Int; 2013 Mar; 62(1):13-20. PubMed ID: 23439054
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-33 and ST2 Signaling in Tumor Microenvironment.
Hong J; Kim S; Lin PC
J Interferon Cytokine Res; 2019 Jan; 39(1):61-71. PubMed ID: 30256696
[TBL] [Abstract][Full Text] [Related]
12. IL-33/ST2 axis in inflammation and immunopathology.
Milovanovic M; Volarevic V; Radosavljevic G; Jovanovic I; Pejnovic N; Arsenijevic N; Lukic ML
Immunol Res; 2012 Apr; 52(1-2):89-99. PubMed ID: 22392053
[TBL] [Abstract][Full Text] [Related]
13. Mast cells are essential intermediaries in regulating IL-33/ST2 signaling for an immune network favorable to mucosal healing in experimentally inflamed colons.
He Z; Song J; Hua J; Yang M; Ma Y; Yu T; Feng J; Liu B; Wang X; Li Y; Li J
Cell Death Dis; 2018 Dec; 9(12):1173. PubMed ID: 30518915
[TBL] [Abstract][Full Text] [Related]
14. IL-33 and the intestine: The good, the bad, and the inflammatory.
Hodzic Z; Schill EM; Bolock AM; Good M
Cytokine; 2017 Dec; 100():1-10. PubMed ID: 28687373
[TBL] [Abstract][Full Text] [Related]
15. Emerging role of the interleukin (IL)-33/ST2 axis in gut mucosal wound healing and fibrosis.
Lopetuso LR; Scaldaferri F; Pizarro TT
Fibrogenesis Tissue Repair; 2012 Oct; 5(1):18. PubMed ID: 23062310
[TBL] [Abstract][Full Text] [Related]
16. IL33: Roles in Allergic Inflammation and Therapeutic Perspectives.
Chan BCL; Lam CWK; Tam LS; Wong CK
Front Immunol; 2019; 10():364. PubMed ID: 30886621
[TBL] [Abstract][Full Text] [Related]
17. Role of type 2 immunity in intestinal inflammation.
Bamias G; Cominelli F
Curr Opin Gastroenterol; 2015 Nov; 31(6):471-6. PubMed ID: 26376478
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic Strategies for Targeting IL-33/ST2 Signalling for the Treatment of Inflammatory Diseases.
Chen WY; Tsai TH; Yang JL; Li LC
Cell Physiol Biochem; 2018; 49(1):349-358. PubMed ID: 30138941
[TBL] [Abstract][Full Text] [Related]
19. The role of the IL-33/IL-1RL1 axis in mast cell and basophil activation in allergic disorders.
Saluja R; Ketelaar ME; Hawro T; Church MK; Maurer M; Nawijn MC
Mol Immunol; 2015 Jan; 63(1):80-5. PubMed ID: 25017307
[TBL] [Abstract][Full Text] [Related]
20. IL-33 Receptor-Expressing Regulatory T Cells Are Highly Activated, Th2 Biased and Suppress CD4 T Cell Proliferation through IL-10 and TGFβ Release.
Siede J; Fröhlich A; Datsi A; Hegazy AN; Varga DV; Holecska V; Saito H; Nakae S; Löhning M
PLoS One; 2016; 11(8):e0161507. PubMed ID: 27548066
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
